Right to Health
10 June 2010
Pharmaceutical Companies Intervene in Support of the Government in the Drug Pricing Case... EIPR: price reductions for 40 drugs are not a result of the new pricing system; the minister’s decree is in the interest of business
On Monday, 7 June 2010, the Supreme Administrative Court heard the appeal filed by the Ministry of Health challenging a ruling from a lower court suspending work under the new drug pricing system. If implemented, the system established by Decree 373/2009 would have lead to a sharp increase in drug prices.